Bobby Singh Ph.d.
Chief Technology Officer and Vice President, Resea
Pharmaceutical science
Corium
United States of America
Biography
Dr. Singh has more than 20 years of experience in the pharmaceutical and drug delivery industries. He is the Chief Technology Officer and Vice President, Research and Development at Corium. Dr. Singh previously held R&D and senior management positions at Ciba-Geigy AG, Novartis, and Vyteris, Inc. He has led the development of several novel passive and active transdermal technology platforms, which resulted in commercialization of a number of transdermal and oral healthcare products. Dr. Singh has published more than 40 publications in peer-reviewed journals and has more than 25 issued and pending patents. He holds a Ph.D. in Pharmaceutics from the University of Queensland, Australia and completed a Post-Doctoral fellowship at the University of California at San Francisco. He is a member of the American Association of Pharmaceutical Scientists and the Controlled Release Society.
Research Interest
Pharmaceutical science,Transdermal technology
